{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:17:38Z","timestamp":1778786258200,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009655","name":"Sunovion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["208340\/Z\/17\/Z"],"award-info":[{"award-number":["208340\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/T003189\/1"],"award-info":[{"award-number":["EP\/T003189\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/V052462\/1"],"award-info":[{"award-number":["EP\/V052462\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.amjmed.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T23:44:51Z","timestamp":1634255091000},"page":"302-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The Use of Inhaled Corticosteroids for Patients with COPD Who Continue to Smoke Cigarettes: An Evaluation of Current Practice"],"prefix":"10.1016","volume":"135","author":[{"given":"Ian M.","family":"Adcock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya P.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Balkissoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2021.09.006_bib0001","unstructured":"COPD Foundation. Understanding COPD. Available at https:\/\/www.copdfoundation.org\/What-is-COPD\/Understanding-COPD\/Statistics.aspx; Accessed: November 3rd 2021."},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0002","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1378\/chest.13-0809","article-title":"COPD surveillance\u2013United States, 1999-2011","volume":"144","author":"Ford","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pmedr.2018.06.016","article-title":"Promoting smoking abstinence among patients with chronic obstructive pulmonary disease: Initial feasibility","volume":"11","author":"Streck","year":"2018","journal-title":"Prev Med Rep"},{"issue":"12","key":"10.1016\/j.amjmed.2021.09.006_bib0004","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1517\/14656566.2015.1067682","article-title":"A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease","volume":"16","author":"D'Urzo","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"2 Suppl","key":"10.1016\/j.amjmed.2021.09.006_bib0005","first-page":"S28","article-title":"COPD in Primary Care: Key Considerations for Optimized Management: Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs","volume":"67","author":"Yawn","year":"2018","journal-title":"J Fam Pract"},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0006","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41533-017-0040-z","article-title":"Determinants of initial inhaled corticosteroid use in patients with GOLD A\/B COPD: a retrospective study of UK general practice","volume":"27","author":"Chalmers","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"issue":"2","key":"10.1016\/j.amjmed.2021.09.006_bib0007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1378\/chest.111.2.296","article-title":"Prehospitalization inhaled corticosteroid use in patients with COPD or asthma","volume":"111","author":"Jackevicius","year":"1997","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.amjmed.2021.09.006_bib0008","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41577-018-0006-6","article-title":"Targeting cytokines to treat asthma and chronic obstructive pulmonary disease","volume":"18","author":"Barnes","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.amjmed.2021.09.006_bib0009","first-page":"833","article-title":"Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers","volume":"128","author":"Hunninghake","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0010","first-page":"397","article-title":"Cytokine inhibition in the treatment of COPD","volume":"9","author":"Caramori","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2021.09.006_bib0011","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"9795","key":"10.1016\/j.amjmed.2021.09.006_bib0012","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(11)60988-4","article-title":"New insights into the immunology of chronic obstructive pulmonary disease","volume":"378","author":"Brusselle","year":"2011","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.amjmed.2021.09.006_bib0013","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0014","unstructured":"Center for Disease Control and Prevention. Percentage of People with Asthma who Smoke. Source: https:\/\/www.cdc.gov\/asthma\/asthma_stats\/people_who_smoke.htm; accessed September 26, 2018."},{"issue":"8","key":"10.1016\/j.amjmed.2021.09.006_bib0015","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.200511-1746OC","article-title":"Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma","volume":"175","author":"Lazarus","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.amjmed.2021.09.006_bib0016","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.120.6.1917","article-title":"Smoking and airway inflammation in patients with mild asthma","volume":"120","author":"Chalmers","year":"2001","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.amjmed.2021.09.006_bib0017","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1378\/chest.115.5.1271","article-title":"A randomized controlled trial on the effect of inhaled corticosteroids on airways inflammation in adult cigarette smokers","volume":"115","author":"Cox","year":"1999","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.amjmed.2021.09.006_bib0018","first-page":"470","article-title":"Overcoming steroid insensitivity in smoking asthmatics","volume":"9","author":"Ahmad","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.amjmed.2021.09.006_bib0019","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/thorax.57.3.226","article-title":"Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma","volume":"57","author":"Chalmers","year":"2002","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.amjmed.2021.09.006_bib0020","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.200304-503OC","article-title":"Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma","volume":"168","author":"Chaudhuri","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.amjmed.2021.09.006_bib0021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1378\/chest.08-0440","article-title":"Molecular mechanisms of corticosteroid resistance","volume":"134","author":"Adcock","year":"2008","journal-title":"Chest"},{"issue":"32","key":"10.1016\/j.amjmed.2021.09.006_bib0022","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.2174\/138161210793797889","article-title":"Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD)","volume":"16","author":"Adcock","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.amjmed.2021.09.006_bib0023","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","article-title":"Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease","volume":"131","author":"Barnes","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"9678","key":"10.1016\/j.amjmed.2021.09.006_bib0024","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjmed.2021.09.006_bib0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1183\/09031936.00017911","article-title":"Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells","volume":"39","author":"Zijlstra","year":"2012","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0026","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0027","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/ajrccm.159.2.9804080","article-title":"Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers","volume":"159","author":"Morrison","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0028","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/thx.51.5.465","article-title":"Mechanisms of cigarette smoke induced increased airspace permeability","volume":"51","author":"Li","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0029","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/09629359890965","article-title":"Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD","volume":"7","author":"Verheggen","year":"1998","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1165\/ajrcmb.20.1.3276","article-title":"Cigarette smoking causes sequestration of polymorphonuclear leukocytes released from the bone marrow in lung microvessels","volume":"20","author":"Terashima","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0031","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.20040416","article-title":"Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages","volume":"200","author":"Cosio","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/thx.2007.078253","article-title":"Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study","volume":"63","author":"Rogers","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0033","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1189\/jlb.0907625","article-title":"Cigarette smoke stimulates the production of chemokines in mast cells","volume":"83","author":"Mortaz","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0034","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/rccm.200810-1570OC","article-title":"Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice","volume":"179","author":"Marwick","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0035","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jaci.2010.02.003","article-title":"A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease","volume":"125","author":"Marwick","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.amjmed.2021.09.006_bib0036","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.200906-0937OC","article-title":"Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease","volume":"182","author":"To","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0037","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-9255-7-29","article-title":"Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients","volume":"7","author":"Tanni","year":"2010","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0038","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/thoraxjnl-2013-203520","article-title":"Oxidant-induced corticosteroid unresponsiveness in human bronchial epithelial cells","volume":"69","author":"Heijink","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0039","doi-asserted-by":"crossref","first-page":"e87443","DOI":"10.1371\/journal.pone.0087443","article-title":"Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers","volume":"9","author":"Hoonhorst","year":"2014","journal-title":"PloS one"},{"issue":"2","key":"10.1016\/j.amjmed.2021.09.006_bib0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/rccm.201503-0593OC","article-title":"Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin","volume":"193","author":"Mitani","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"19","key":"10.1016\/j.amjmed.2021.09.006_bib0041","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa041892","article-title":"Decreased histone deacetylase activity in chronic obstructive pulmonary disease","volume":"352","author":"Ito","year":"2005","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.amjmed.2021.09.006_bib0042","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1128\/MCB.20.18.6891-6903.2000","article-title":"Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12","volume":"20","author":"Ito","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.amjmed.2021.09.006_bib0043","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/nar\/27.3.711","article-title":"Chromatin disruption and modification","volume":"27","author":"Wolffe","year":"1999","journal-title":"Nucleic Acids Res"},{"issue":"9410","key":"10.1016\/j.amjmed.2021.09.006_bib0044","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(04)15650-X","article-title":"Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase","volume":"363","author":"Barnes","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20050466","article-title":"Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression","volume":"203","author":"Ito","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0046","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1993.tb39148.x","article-title":"Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite","volume":"686","author":"Pryor","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.amjmed.2021.09.006_bib0047","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbrc.2009.04.128","article-title":"Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2","volume":"384","author":"Osoata","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0048","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbrc.2004.01.046","article-title":"Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration","volume":"315","author":"Ito","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.amjmed.2021.09.006_bib0049","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","article-title":"Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease","volume":"60","author":"Brightling","year":"2005","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.amjmed.2021.09.006_bib0050","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.162.5.9910112","article-title":"Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease","volume":"162","author":"Papi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"20","key":"10.1016\/j.amjmed.2021.09.006_bib0051","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199211123272003","article-title":"A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group","volume":"327","author":"Kerstjens","year":"1992","journal-title":"N Engl J Med"},{"issue":"9105","key":"10.1016\/j.amjmed.2021.09.006_bib0052","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(97)03471-5","article-title":"Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group","volume":"351","author":"Paggiaro","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2021.09.006_bib0053","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/thx.53.6.477","article-title":"Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease","volume":"53","author":"Bourbeau","year":"1998","journal-title":"Thorax"},{"issue":"9167","key":"10.1016\/j.amjmed.2021.09.006_bib0054","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(98)10019-3","article-title":"Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial","volume":"353","author":"Vestbo","year":"1999","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.amjmed.2021.09.006_bib0055","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","article-title":"Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease","volume":"340","author":"Pauwels","year":"1999","journal-title":"N Engl J Med"},{"issue":"7245","key":"10.1016\/j.amjmed.2021.09.006_bib0056","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"issue":"26","key":"10.1016\/j.amjmed.2021.09.006_bib0057","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJM200012283432601","article-title":"Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease","volume":"343","author":"Wise","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0058","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/thx.54.1.7","article-title":"Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis","volume":"54","author":"van Grunsven","year":"1999","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.amjmed.2021.09.006_bib0059","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","author":"Yang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.amjmed.2021.09.006_bib0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/14656566.2020.1845314","article-title":"Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review","volume":"22","author":"Ritondo","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0061","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Committee. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2018 Report."},{"key":"10.1016\/j.amjmed.2021.09.006_bib0062","article-title":"Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)","volume":"2","author":"Horita","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.amjmed.2021.09.006_bib0063","article-title":"Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis","author":"Kew","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"10.1016\/j.amjmed.2021.09.006_bib0064","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjmed.2021.09.006_bib0065","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2021.09.006_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"141","author":"Yun","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.amjmed.2021.09.006_bib0067","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.amjmed.2021.09.006_bib0068","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.201612-2525LE","article-title":"Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease","volume":"196","author":"Calverley","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0069","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/096293500411578","article-title":"Effect of an inhaled glucocorticoid on reactive oxygen species production by bronchoalveolar lavage cells from smoking COPD patients","volume":"9","author":"Verhoeven","year":"2000","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0070","first-page":"273","article-title":"Differences in responses upon corticosteroid therapy between smoking and non-smoking patients with COPD","volume":"57","author":"Van Overveld","year":"2006","journal-title":"J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.amjmed.2021.09.006_bib0071","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/15412550701341186","article-title":"Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes","volume":"4","author":"Vollmer","year":"2007","journal-title":"COPD"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0072","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200906-0876OC","article-title":"Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease","volume":"180","author":"Celli","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0073","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1183\/09031936.00082909","article-title":"Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial","volume":"35","author":"Tashkin","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0074","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pupt.2010.07.003","article-title":"Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender","volume":"24","author":"Tashkin","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12931-018-0830-z","article-title":"Indacaterol\/glycopyrronium versus salmeterol\/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study","volume":"19","author":"Anzueto","year":"2018","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.amjmed.2021.09.006_bib0076","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01393-2017","article-title":"Cigarette smoking and response to inhaled corticosteroids in COPD","volume":"51","author":"Bhatt","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0077","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0078","first-page":"A2389","article-title":"Lung function and patient-reported outcomes response to indacaterol\/glycopyrrolate (UTIBRON(TM) Neohaler(R)) in chronic obstructive pulmonary Disease (COPD) patients by smoking status: pooled analysis of the FLIGHT1 and FLIGHT2 studies","volume":"197","author":"Sanjar","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjmed.2021.09.006_bib0079","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1164\/rccm.201505-1048OC","article-title":"FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol\/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease","volume":"192","author":"Mahler","year":"2015","journal-title":"Am J Respir Crit Care Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321006410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934321006410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:30:07Z","timestamp":1762079407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934321006410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0002934321006410"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.09.006","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Inhaled Corticosteroids for Patients with COPD Who Continue to Smoke Cigarettes: An Evaluation of Current Practice","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}